כל המחקרים
גיוסשלב 2התערבותי

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

The NODE-202 study is a clinical trial exploring a new nasal spray treatment, Etripamil, for children and teenagers (aged 6-17 years old) who experience a rapid heart rate condition known as Paroxysmal Supraventricular Tachycardia (PSVT). This study is in its second phase, meaning it's still an early stage of testing. Researchers want to find out if the nasal spray is effective and safe to use as a single dose when someone is having a PSVT episode. It will involve different age groups, starting with older teenagers and then moving to younger children, carefully checking the right dose and how the body handles the treatment. The goal is to see if this easy-to-use spray could be a helpful option for managing PSVT.

במבט חטוף

סטטוס
גיוס
שלב
שלב 2
נותן חסות
Milestone Pharmaceuticals Inc.
יעד הרשמה
60
התחל
11 דצמבר 2023
השלמה משוערת
30 יוני 2027

על מה המחקר הזה?

This study, called NODE-202, is looking into a potential new treatment for a heart condition known as Paroxysmal Supraventricular Tachycardia, or PSVT. If you or your child has PSVT, you'll know that it causes your heart to suddenly beat very quickly. This study is testing a new medicine called Etripamil, which is given as a nasal spray, to see if it can help stop these fast heart episodes. It's a 'Phase 2' study, which means it's an early step in researching new medicines, focusing on whether it works and if it's safe for children and teenagers.

The study involves different age groups, starting with young people aged 12 to 17 years old, and then potentially moving on to younger children aged 6 to 11. The researchers will give a single dose of the nasal spray to participants when they are having a PSVT episode and watch closely to see if it brings their heart rate back to normal. They will also be checking for any side effects and how the body handles the medicine.

The main aim is to find the right dose and make sure the treatment is safe and tolerable for children. By taking part, you or your child could help doctors learn more about managing PSVT and potentially help develop a new, easier way to treat this condition at home.

נקודות עיקריות

  • This study is testing a new nasal spray for fast heartbeats (PSVT) in children and teenagers.
  • It's an early-stage study to check if the medicine works and is safe.
  • Participants will receive a single dose of the nasal spray if they have a PSVT episode.
  • Different age groups from 6 to 17 years old are included.
  • Participation will involve a few hospital visits.
  • You can stop taking part in the study at any time.

מי עשוי להיות זכאי?

To join this study, participants generally need to be male or female, aged between 6 and 17 years old, and have a confirmed diagnosis of PSVT. Their heart condition must specifically involve a part of the heart called the AV node, and any past treatments for PSVT, like surgery, must show that the PSVT can still happen.

There are also some important health conditions that would prevent someone from joining. For example, if you or your child has other serious heart problems like certain types of irregular heartbeats (like atrial fibrillation or Wolff-Parkinson-White syndrome), or if they have had significant heart surgery that left major issues, they wouldn't be able to participate. It's important that participants are able and willing to follow the study's instructions.

For female participants who are old enough to have periods, they would need to have a negative pregnancy test at the start and agree to use effective contraception throughout the study, unless they are not sexually active. These checks are in place to ensure everyone's safety during the trial.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. Are you or your child between 6 and 17 years old?
  2. Do you or your child have a confirmed diagnosis of PSVT?
  3. Is your PSVT related to the AV node in the heart?
  4. Do you or your child have other serious heart problems?
  5. Are you or your child able to come to all study appointments?
  6. For females of childbearing potential, are you able to use contraception during the study?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

Taking part in this study would involve a few steps. First, there would be a 'Screening Visit' to check if you or your child meets all the criteria to join. If you're eligible, the main part is the 'Treatment Visit', where, if a PSVT episode occurs, a single dose of the Etripamil nasal spray will be given. During this visit, doctors will carefully monitor the heart and check for any changes or side effects. There might also be blood tests to see how the medicine is processed by the body. After the treatment, there will be a 'Follow-Up/End of Study Visit' to make sure everything is well.

The study itself is divided into different parts and age groups, but each participant will only receive a single dose if they experience a PSVT episode during the trial. The total duration of your individual participation would include these few visits, from the initial checks to the final follow-up, ensuring doctors have all the information they need about the medicine's effects.

סיכונים ותועלות פוטנציאליים

Potential benefits of taking part include helping researchers learn more about how to treat PSVT, which could lead to a new treatment option in the future. You or your child might also receive closer medical attention than usual. However, there are potential risks, just like with any medicine. These could include side effects from the nasal spray, which the doctors will monitor closely. It's important to remember that this is an experimental medicine, and it might not work for everyone. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

מיקומים (10)

  • בית החולים לילדים פיניקס
    מיקוד מאומת
    פניקס, ארצות הברית· גיוס
  • Advocate Children's Hospital
    מיקוד מאומת
    Oak Lawn, United States· עדיין לא מגייסים
  • מרכז רפואי בית חולים לילדים סינסינטי
    מיקוד מאומת
    סינסינטי, ארצות הברית· עדיין לא מגייסים
  • Oregon Health and Science University
    מיקוד מאומת
    פורטלנד, ארצות הברית· גיוס
  • Le Bonheur Children's Hospital
    מיקוד מאומת
    Memphis, United States· עדיין לא מגייסים
  • Baylor College of Medicine
    מיקוד מאומת
    יוסטון, ארצות הברית· עדיין לא מגייסים
  • The University of British Columbia
    מיקוד מאומת
    ונקובר, קנדה· עדיין לא מגייסים
  • Universitätsmedizin Göttingen, Klinik für Pädiatrische Kardiologie, Intensivmedizin und Neonatologie
    מיקוד מאומת
    Göttingen, Germany· עדיין לא מגייסים
  • Hospital Sant Joan de Déu
    מיקוד מאומת
    ברצלונה, ספרד· עדיין לא מגייסים
  • Hospital Infantil Universitario La Paz
    מיקוד מאומת
    מדריד, ספרד· גיוס

שאלות נפוצות

What is PSVT?

PSVT stands for Paroxysmal Supraventricular Tachycardia, which is a condition where the heart suddenly beats very fast and then returns to a normal rhythm.

What is Etripamil nasal spray?

Etripamil nasal spray is a new medicine being tested in this study to see if it can help stop episodes of fast heartbeats caused by PSVT when sprayed into the nose.

Will I or my child definitely get the new medicine?

If eligible, participants will receive a single dose of the Etripamil nasal spray during the study, specifically when experiencing a PSVT episode.

How long does the study last for each person?

Each participant's involvement includes a screening visit, a treatment visit where the medicine is given (if a PSVT episode occurs), and a follow-up visit. The exact timeframe will vary but will be discussed with you.

Is this medicine available to the public?

No, Etripamil is currently an experimental medicine and is only available to patients participating in specific clinical trials like this one.

כיצד לגלות עוד

Cameron Szakacs, PhD

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "The NODE-202 Study (Study of Etripamil Nasal Spray in Pediat…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.